Foresight Diagnostics

Foresight Diagnostics Inc. specializes in developing advanced diagnostic solutions for early cancer detection and monitoring. They generate revenue through the sale of their proprietary liquid biopsy tests, which provide non-invasive, highly sensitive detection of minimal residual disease (MRD) and recurrence in cancer patients. Founded by leading experts in oncology and genomics, the company has rapidly gained recognition for its innovative technology and commitment to improving patient outcomes. Their cutting-edge approach leverages next-generation sequencing and machine learning to deliver precise and actionable insights for personalized cancer care.

Recent Posts by Foresight Diagnostics

1-20 of 25